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as Possible Biomarkers in Early Detection 
of Acute Kidney Injury after Cardiac Surgery
IntROduCtIOn
Acute kidney injury is a serious and fatal complication that occurs in 
1-2% of patients after cardiac surgery [1,2]. Patients with AKI need 
dialysis; mortality among these patients is over 60% [1,2]. In less 
severe AKI, cases that do not need dialysis, short-term mortality 
increases 19-fold [3]. In mild AKI in which serum creatinine levels 
increase by 25%, over a long time to 10 years after surgery, mortality 
is doubled [4].
It is thought that the most important mechanism of kidney injury 
is intraoperative ischaemia-reperfusion injury. The obtained results 
from animal studies have indicated that AKI may recur when the 
therapeutic intervention is performed at the shortest time after 
surgery or during the beginning time or at the early extension phase 
of ischaemia-reperfusion injury [5-8].
It has been determined that kidney injuries are partly caused due to 
lack of specific and real-time sensitive markers that cannot achieve 
early diagnosis of AKI [9]. Right now, serum creatinine is the AKI 
diagnostic marker; however, its increase is delayed, which causes 
postponement of the treatment processes [10,11]. Serum creatinine 
is not a precise marker for Glomerular Filtration Rate (GFR) in stable 
condition [12]; therefore, acute changes in serum creatinine at the 
time of AKI may lack proper precision and may not accurately reflect 
the severe changes in GFR.
Many studies have been performed in the clinical care and clinical 
trials to find biomarkers for early diagnosis of AKI with the aim of 
achieving more time for AKI treatment [13,14]. Although, there have 
been some advances in this field, creatinine is still the common 
reference for comparing new biomarkers of kidney injury [15].
Cys C as a novel biomarker is detected in serum earlier than creatinine 
(about 24-48 hours). Cys C is not affected by tubular secretion 
and glomerular filtration; so urine Cys C can reflect the glomerular 
filtration function as well as its serum concentration [16].
Cys C is a much more precise estimator of GFR than creatinine 
and it has more diagnostic value for chronic kidney disease [12,17]. 
Some studies have demonstrated the importance of Cys C in 
early detection of kidney injury after heart surgery [18,19]. Cys C 
concentration increases within two hours after heart surgery and 
reaches to a peak at six hours after cardiopulmonary bypass [20].
Another novel marker for AKI is urinary NGAL. Different clinical 
studies have indicated that increase in serum and urine NGAL is an 
independent predictor of serum creatinine for AKI diagnosis [21,22]. 
A meta-analysis had shown the diagnosis and prognosis accuracy of 
NGAL for AKI identification [9]. Also, it is reported that urinary NGAL 
significantly reaches to its peak (400 ng/mL) within 2-4 hours after AKI 
[23]. Similar to Cys C, NGAL can be a better marker than creatinine.
Expression of various MMPs is different in different parts of kidney; 
for example, MMP-9 is widely expressed in the glomerulus and is 
considered as a prognostic factor in patients undergoing surgery [24]. 
The role of MMPs has been demonstrated in the pathophysiology of 
numerous chronic and acute renal diseases such as renal ischaemic 
Sara Bagheri1, Nahid eiNollahi2, MohaMMad Taghi goodarzi3, haSSaN TaTari4, 
heMeN Moradi-Sardareh5, NaSriN Sheikh6
 
Keywords: Cardiac surgery, Creatinine, Gel zymography
ABStRACt
Introduction: Acute Kidney Injury (AKI) often occurs after open 
heart surgery. Today, serum creatinine is used as an indicator for 
identifying AKI; however, creatinine is unreliable due to delay in 
its elevation. Therefore, more reliable markers are required for 
early diagnosis of AKI.
Aim: To measure the changes in Neutrophil Gelatinase-
Associated Lipocalin (NGAL) and Cystatin C (Cys C) levels 
and Matrix Metallo Proteinase 9 (MMP-9) activity in serum of 
patients who underwent cardiac surgery.
Materials and Methods: The present descriptive study 
was conducted from September to October 2015 among 
patients referred to Cardiovascular Surgery Center at Shahid 
Modarres Hospital in Tehran, Iran. Urine and serum sample 
from 29 candidates for cardiac surgery were collected at 6 
and 12 hours after surgery. On the basis of increase in serum 
creatinine, the patients were divided into two groups; AKI and 
control group. AKI group had at least 50% increase in serum 
creatinine; those with less than 50% increase were considered 
as control group. Urine NGAL and Cys C concentrations were 
measured using ELISA; MMP-9 activity was determined using 
gel zymography.
Results: The results showed an increase in Cys C concentration 
in AKI group compared to control group after 6 and 12 hours of 
surgery. The comparison of Cys C concentration in AKI group 
between 6 and 12 hours after surgery showed no significant 
difference. The comparison of NGAL at 12 hours after surgery 
between control and AKI groups showed no significant 
difference. The MMP-9 activity showed a decreasing trend in 
AKI group compared to control group at 12 hours after surgery. 
Decrease in MMP-9 activity in AKI group at 6 hours after surgery 
was statistically different from after 12 hours of surgery.
Conclusion: Present results provide evidence that Cys C and 
MMP-9 can be better reliable markers for early detection of AKI 
as compared to serum creatinine, after cardiac surgery. NGAL 
did not show higher sensitivity compared to creatinine in these 
patients. Therefore, Cys C and MMP-9 can be suggested as 
biomarkers for early detection of AKI after cardiac surgery.
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The protocol of this study was approved by ethics committee of 
Hamadan University of Medical Sciences. 
StAtIStICAL AnALYSIS
Statistical analysis was done by SPSS v.21. Student t-test was 
used for comparing the data between two groups; paired t-test 
was used to compare the data at different times in each group. 
Correlation analysis was carried out using Pearson test to examine 
any relationship between the studied factors (NGAL, Cys C, MMP-9). 
A p-value less than 0.05 was considered significant.
RESuLtS
The patients’ demographic characteristics are shown in [Table /Fig-1]. 
The mean concentration of Cys C at 6 and 12 hours after surgery 
in control group were 702.58±49.82 ng/mL and 713.37±70.83 ng/
mL respectively and the difference was not significant (p=0.865). 
In AKI group, the mean concentration of Cys C at the same times 
(6 and 12 hours) was 1626.42±385.73 ng/mL and 1856.13±413.9 
ng/mL, respectively and the difference was not significant (p=0.551) 
[Table/Fig-2a].
damage. In the development of AKI, increased expression of 
different MMPs (2, 3, 24, 25, 27, 28, 13, 9 and 14) is reported [24]. 
Also, an association between cardiac surgery and increased activity 
of MMPs is proven. Heart surgery induces neutrophil activation, 
degranulation and some systemic inflammatory responses. The 
neutrophils contain MMPs and release them during activation 
[25]. In the present study, we tried to examine three markers and 
to compare them together and with serum creatinine in patients 
undergoing cardiac surgery and to find possible biomarkers for 
early detection of AKI in these patients.
MAtERIALS And MEthOdS
This descriptive study was conducted from September to October 
2015 among the patients referred to Cardiovascular Surgery Center 
at Shahid Modarres Hospital in Tehran city, Iran. From all of the 
patients who underwent open-heart surgery, 29 patients as per the 
exclusion criteria were selected and included in the study. Exclusion 
criteria for the study: using nephrotoxic drugs before surgery, 
history of kidney failure, urinary tract obstruction, consumption of 
nonsteroidal anti-inflammatory drugs in couple of weeks before 
surgery or first three days after surgery, history of neoplastic 
diseases, and history of stroke during six months before surgery.
Written informed consent was obtained from every participant before 
enrollment. A serum sample at two intervals (6 and 12 hours) after 
surgery was obtained from all individuals; creatinine was measured 
in these samples using routine tests. According to increase in serum 
creatinine, the patients were divided to two groups (AKI and control). 
AKI group (n=12) had at least 50% increase in serum creatinine; 
those with less than 50% increase were considered as controls 
(n=17).
Blood and urine samples were collected from control and AKI 
patients. After 12 hours of surgery, urine specimens were obtained 
from all patients, centrifuged for five minutes at 2000 g, and the 
supernatant was stored in aliquots at -80°C. Serum creatinine was 
measured using Jaffe’s colorimetric method (Pars Azmun Kit, Iran), 
according to the kit manufacturer and monitored at least twice a 
day during  the next three days after surgery.
Blood samples were collected from control and AKI groups at 6 
and 12 hours after surgery and allowed to clot at room temperature 
then centrifuged at 1000 g for 10 minutes; serum was separated, 
aliquoted and kept at -80°C.
The first outcome that was defined as AKI extension was 50% or 
more increase of serum creatinine from the baseline.
Cys C and NGAL markers were measured using sandwich Enzyme 
Linked Immunosorbent Assay (ELISA) and enzyme immunoassay 
(BioVendor, Catalogue. No.: RD191009100 and RD191102200R, 
respectively) based on manufacturer protocol. Kit sensitivity of Cys 
C and NGAL was 0.02 ng/mL and 0.25 ng/mL, respectively. 
Gelatin Zymography
The activity of MMP-9 was determined using gelatin zymography 
method. Concentration of serum protein was quantitated 
by Bicinchoninic Acid (BCA) assay then 10 µg protein from 
each specimen was subjected to zymography. In summary, 
electrophoresis (BioRad, USA) was done on 10% polyacrylamide 
gel (Merck, Germany) containing 0.3% gelatin (Bio-Rad) and under 
non reducing condition. After electrophoresis, gel was washed 
two times for one hour in 2.5% Triton X-100 (Sigma) solution to 
remove SDS (BioBasic), then incubated for 16 hours at 37°C 
in zymography buffer (Tris-HCl buffer with pH=7.4 containing 
10 mM calcium chloride) (Merck, Germany) and stained with 5% 
Coomassie Brilliant Blue G250. Gel densitometry analysis was 
performed by the Image J 1.44p application (Wayne Rasband, 
National Institutes of Health, USA) and MMP-9 activity estimated 
by the use of gelatin lytic activity [26].
Characteristics aki (n=12) Control (n=17)
Age (years) (mean±SD) 62.45±8.04 57.58±15.07
Gender (female/male) 11/1 11/6
BMI (mean±SEM) 26.02±1.41 27.04±1.21
Pumps time (minute) (mean±SEM) 106.18±10.19 114.94±9.41
Cross clamp time 65.72±8.73 79.68±10.06
Ejection fraction
<35% 3 (25%) 3 (17.6%)
>35% 9 (75%) 14 (82.4%)
[table/Fig-1]: Demographic characteristics of the study population.
Postoperative Cys C concentration in AKI group showed a 
remarkable increase compared to that of control group. Cys C 
concentration comparison between AKI and control group showed 
significant difference at six hours after surgery (p=0.003) as well as 
at 12 hours after surgery (p=0.002) [Table/Fig-2b].
[table/Fig-2a]: Cystatin C levels at different time intervals.
*p-value<0.05, Student t-test
Cystatin C 
(ng/ml)
Time (hours) group Mean SeM p-value
6
Control 702.58 49.82
0.003
AKI 1626.42 385.73
12
Control 713.37 70.83
0.002
AKI 1856.13 431.90
[table/Fig-2b]: Cystatin C comparison between the studied groups at 6 and 12 hour 
postoperatively.
SEM: Std. error mean; p-value was calculated using Student t-test; p-value <0.05 was considered 
significant.
The mean activity of MMP-9 in control group at 6 and 12 hour after 
surgery were 1.91 AU and 1.92 AU, respectively and did not show 
any significant difference (p=0.790). In contrast to control group, 
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be detectable [27]. For this reason, the minimum required time for 
its increase in serum is 24-48 hours and consequently this marker 
has some limitations for early diagnosis of AKI. Researchers have 
identified some new markers in the recent years that have an 
appropriate sensitivity and prediction power for AKI incidence after 
heart surgery [28,29].
In the present study the changes in some biomarkers including 
MMP-9, Cys C and NGAL were studied in patients who underwent 
cardiac surgery. The results showed that the MMP-9 activity in 
AKI group after open-heart surgery did not increase; however a 
remarkable reduction was observed after 12 hours (2.05 to 1.57 AU) 
(p-value=0.002). This was different from what was observed in control 
group. In the latter group, no significant changes were observed 
between two interval times (6 and 12 hours) (p-value=0.790). The 
present study could not identify the primary cause of MMP-9 activity 
reduction in AKI group, but based on the results observed in two 
independent samples it could conceivably be hypothesised that: 1) it 
is likely that an unknown pathway exists at the time of high creatinine 
level that is implicated in the controlling of gene expression and/or 
activity of the MMP-9; and 2) the peak of MMP-9 concentration after 
heart surgery is in the early hours after surgery (2-6 hours) and after 
this time the concentration of MMP-9 gradually reduces. The latter 
hypothesis was supported by other studies that indicated MMP-9 
reduction at 12 hour postoperation [25,30].
The scientists developed a unilateral ischaemia model on rats in 
order to consider the effect of acute ischaemia on gelatinase activity 
and expression in kidney; they concluded that ischaemia reperfusion 
injury increases the serum creatinine level and it was considered as 
a marker for diagnosis of kidney injury [31,32]. Ischaemia reperfusion 
injury has been known as a strong potential stimulus for induction 
of mRNA and protein expression of MMP-9 in both monomer and 
dimer forms [31,32]. These researchers by doing zymography in 
another study showed that ischaemia reperfusion injury strongly 
increases the pro-MMP-2 proteolytic activity to 1.8 folds pro-MMP-9 
to 3 folds, and MMP-9 to 4 folds [31,32]. These findings indicated that 
ischaemia-reperfusion injury in kidney can lead to increase basement 
membrane destruction and blood vessels permeability [31,32].
Cys C has been considered as an early biomarker for AKI diagnosis 
and it has been shown that it increases before serum creatinine 
[14,33]; besides, it has been mentioned that Cys C concentration 
is less affected by the volume status than serum creatinine [34]. 
There are some reports that show serum Cys C elevation occurs 
before slight reduction of GFR (one or two days before beginning 
of symptoms), and even before increase in serum creatinine and 
kidney function reduction [35,36]. The primary increase of urinary 
Cys C level is a good predictor for AKI after heart surgery [37].
Some studies indicated Cys C concentration can immediately predict 
moderate and very severe AKI development after heart surgery [38]. 
Zappitelli M et al., showed that AKI, as defined by severe increase 
of Cys C, has a stronger correlation with the two urinary markers of 
kidney injury (IL-18 and KIM-1) than serum creatinine [39].
The finding of the present study indicated that in AKI group 
compared with control group, serum Cys C concentration was 
higher and this result showed that injury in kidney (at any level) 
leads to increase in serum Cys C and creatinine. The comparison 
of serum Cys C concentration at 6 hours postoperation between 
control and AKI group indicated a significant increase in AKI group 
(p-value=0.003). This result indicated that Cys C can be a good 
marker for AKI diagnosis in patients after open-heart surgery. On 
the other hand, since the comparison of Cys C concentration did 
not show a significant difference at 6 and 12 hours postoperation 
among AKI group, it can be concluded that this marker may increase 
in early hours after surgery and the rate of this increase may be 
slower after six hours, because it did not increase significantly at 
12 hours postoperation. Therefore, it can be concluded that Cys 
[table/Fig-3a]: MMP levels at different time intervals.
p-value was calculated using paired t-test; **p-value <0.01 was considered significant
*p-value <0.05, Student t-test
Paired samples statistics
MMP-9
groups Time (hours) Mean N p-value
Control
6
1.91 17
0.517
AKI 2.05 12
Control
12
1.92 17
0.030
AKI 1.57 12
[table/Fig-3b]: MMP-9 activity comparison between the studied groups at 6 and 
12 hours postoperatively.
p-value <0.05, Student t-test
Ngal (ng/ml)
group Mean SeM p-value
Control 19.41 4.33
0.879
AKI 26.34 11.20
[table/Fig-4]:  Urinary NGAL comparison between two groups 12 hours 
 postoperatively. No significant difference was observed between two groups.
SEM: Std. error mean; Student t-test; p<0.05 was considered significant
in AKI group there was a significant difference in MMP-9 activity 
between 6 and 12 hours after surgery (2.05 AU and 1.57 AU 
respectively, p=0.002) [Table/Fig-3a].
The MMP-9 activity comparison at six hours postoperation did not 
show any significant difference between AKI and control groups 
(p=0.517); however, a reduced activity in AKI group was observed 
at 12 hours postoperation that was significantly different compared 
to that of control group (p=0.03) [Table/Fig-3b]. Also, the observed 
reduction in MMP-9 activity was significant at 12 hours compared 
to six hours postoperation in AKI group.
The comparison of mean concentration of urine NGAL did not show 
significant difference after surgery in AKI comparing to control group 
(p=0.879) [Table/Fig-4].
There was a positive correlation between urine NGAL and creatinine 
concentration in both pre and postoperative days (p=0.008, r=-0.48 
and p=0.046 and r=+0.37, respectively), but there was no significant 
correlation between MMP-9 activity and Cys C concentration with 
serum creatinine concentration changes (p=0.979, r=+0.005; 
p=0.907, r=-0.023; p=0.367, r=-0.174; p=0.549, r=-0.116, 
respectively). None of the studied markers showed a significant 
relation with age, gender, BMI, pumps time, cross clamp time, and 
ejection fraction variables (p>0.05).
Cys C concentration in patients after surgery had significant and 
direct correlation with the length of stay in ICU (p=0.002, r=+0.54). 
There was a negative significant correlation between MMP-9 activity 
and serum creatinine at 12 hours postoperation (p=0.04, r=-0.50) 
in control group. 
dISCuSSIOn
Serum creatinine is not a real-time reflector of GFR because it 
must accumulate in serum as a result of GFR reduction that can 
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C is an appropriate early marker to consider for kidney function 
after open-heart surgery; this marker can be measured in the initial 
hours (before 12 hours) postoperation for rapid and early detection 
of GFR changes. The obtained results were in line with some 
previous studies that reported serum Cys C has enough power 
and sensitivity in early diagnosis of acute kidney failure after heart 
surgery [40-42]; even Cys C serum concentration after surgery is 
used as an appropriate marker to classify AKI patients (1 and 2 
stages) for treatment [38].
A number of studies demonstrate conflicting results about the 
early detection of AKI after cardiac surgery by Cys C. Zappitelli 
M et al., reported that identifying AKI by Cys C is much later 
than by creatinine (the average diagnosis time 48 and 24 hours, 
respectively) [39]; however, most of these patients were in Stage I 
AKI which was verified by creatinine assay. The reason of increased 
creatinine in these patients may be due to increased production, 
secretion and metabolism of creatinine, and not exactly due to 
renal tubular injury. Their theory was supported by the correlation 
between Cys C and some biomarkers that had been studied; 
therefore, they concluded that even though the mean Cys C is 
identifiable after creatinine, it does not essentially mean that Cys C 
is a delayed biomarker [39].
In the present study, NGAL in urine after open-heart surgery was 
considered as a contributory factor in early diagnosis of kidney 
injuries. Although, this marker had a relative increase in AKI group 
compared to control group after surgery, its changes were not 
statistically significant (p-value=0.879); however, this result showed 
that using this marker could not be a good alternative for creatinine 
in kidney injury diagnosis, this result was in contrast with some 
published reports [9,23].
Our results indicated that urinary NGAL had a very little ability in AKI 
diagnosis after heart surgery and it was in line with other studies 
[37,43]. It was indicated in a review that the common markers in 
the best situation have a low diagnostic power for AKI detection in 
short time after heart surgery in adults [29]. In another review study 
Hjortrup PB et al., realised that different study results are very diverse 
in early identification of AKI by NGAL; these results are different 
from that indicated NGAL is worthless to have a good diagnostic 
value in the field of AKI [27]. Watanabe M et al., observed a positive 
correlation between serum creatinine and urinary NGAL in AKI 
patients; the highest concentration of serum creatinine correlated 
to higher values of urinary NGAL [44]. These results were in line with 
this study finding that showed a positive correlation between urinary 
NGAL and serum creatinine before and after surgery.
LIMItAtIOn
One of the important limitation of this study was the small number 
of patients in each group, also the small study duration; therefore, it 
can be considered as a preliminary report.
COnCLuSIOn
It can be concluded that Cys C and MMP-9 can be the reliable 
markers for early detection of AKI comparing to serum creatinine 
in patients after cardiac surgery. According to the obtained data, 
NGAL cannot be recommended as a sensitive marker in these 
patients. 
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